Korczynski Sherry 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Korczynski Sherry（CIK 2026090）在 1 家公司共报告 8 笔 SEC Form 4 内部人交易（最近一笔 2026-09-11）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-11 | Aquestive Therapeutics, Inc. (AQST) | Chief Commercial Officer | 买入 | 8,750 | $23,188 |
| 2026-09-11 | Aquestive Therapeutics, Inc. (AQST) | Chief Commercial Officer | 卖出 | 8,750 | $45,675 |
| 2026-08-17 | Aquestive Therapeutics, Inc. (AQST) | Chief Commercial Officer | 卖出 | 2,714 | $11,534 |
| 2026-06-09 | Aquestive Therapeutics, Inc. (AQST) | Chief Commercial Officer | 卖出 | 2,714 | $0 |
| 2026-03-11 | Aquestive Therapeutics, Inc. (AQST) | Chief Commercial Officer | 买入 | 75,000 | $0 |
| 2026-03-11 | Aquestive Therapeutics, Inc. (AQST) | Chief Commercial Officer | 卖出 | 15,741 | $65,640 |
| 2025-08-15 | Aquestive Therapeutics, Inc. (AQST) | Chief Commercial Officer | 买入 | 25,000 | $0 |
| 2025-06-10 | Aquestive Therapeutics, Inc. (AQST) | SVP Sales and Marketing | 卖出 | 2,714 | $9,608 |
来源：SEC Form 4 申报文件 · 截至 2026-09-11